• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0702
Device Problems Difficult to Insert (1316); Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/23/2023
Event Type  Injury  
Event Description
This will be filed to report a loss of fluid column.It was reported that a patient presented with grade 3 functional mitral regurgitation (mr) and a dilated atrium.During a mitraclip procedure, the steerable guide catheter (sgc) was positioned in the left atrium.Inserting the clip introducer into hemostasis valve of the sgc was presented with difficulty.The clip introducer could not be inserted, and a loss of column was observed from the hemostasis valve.Air was also observed in the sgc, which required additional aspiration outside of standard procedure.The sgc was removed and replaced.The clip introducer was able to be inserted and the procedure was successful.The mr was reduced to grade <1.There were no adverse patient effects or clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
All available information was investigated, and the reported leak / splash (loss of fluid column during procedure) and difficult to insert (cds into sgc) was confirmed via returned device analysis.Additionally, the sgc hemostasis valve was observed to be torn.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the reported leak/splash (loss of fluid column during procedure) appears to be due to the torn sgc hemostasis valve.The reported difficult to insert (cds into sgc) was also due to the torn sgc hemostasis valve as the clip introducer¿s insertion pathway would likely be obstructed.A cause of the observed torn hemostasis valve could not be determined.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER (CE)
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17128509
MDR Text Key317210597
Report Number2135147-2023-02576
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/12/2024
Device Catalogue NumberSGC0702
Device Lot Number30213R1083
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/23/2023
Initial Date FDA Received06/14/2023
Supplement Dates Manufacturer Received06/23/2023
Supplement Dates FDA Received07/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MITRACLIP; MITRACLIP
Patient Outcome(s) Required Intervention;
-
-